Singh Jagjeet, Phogat Annu, Kumar Vijay, Malik Vinay
Department of Zoology, Maharshi Dayanand University, Rohtak, India.
Department of Biochemistry, Maharshi Dayanand University, Rohtak, India.
Toxicol Mech Methods. 2022 Nov;32(9):686-694. doi: 10.1080/15376516.2022.2064258. Epub 2022 Apr 21.
Monocrotophos (MCP) is an organophosphate pesticide with well-known toxicity in mammals. Exposure of MCP is associated with altered molecular physiology at sub-cellular levels. This study investigated the efficacy of -acetylcysteine (NAC) against MCP exposure mediated mitochondrial dysfunctions in hepatic tissue of rats. Male Wistar rats were given NAC (200 mg/kg b.wt), MCP (0.9 mg/kg b.wt) and NAC together with MCP, intragastrically for 28 consecutive days. Mitochondrial complexes activities were evaluated using biochemical analysis. mRNA expression of mitochondrial complexes subunits, PGC-1α and its downstream regulators were analyzed using polymerase chain reaction. Exposure of MCP (0.9 mg/kg b.wt, intragastrically, 28 d) decreased mitochondrial complexes activities and gene expression of complexes subunits. The expression of PGC-1α, NRF-1, NRF-2, and Tfam was also reduced significantly. The administration of NAC (200 mg/kg b.wt, intragastrically, 28 d) significantly increased mitochondrial complexes activities and gene expression of complexes subunits. Additionally, NAC also maintained mitochondrial functions, and enhanced the gene expression of PGC-1α and its downstream regulators. The results of this study indicate that NAC prevents hepatic mitochondrial dysfunctions and maintains PGC-1α signaling. In conclusion, NAC might be speculated as a therapeutic agent for mitochondrial dysfunctions following toxic exposures.
久效磷(MCP)是一种在哺乳动物中具有众所周知毒性的有机磷酸酯农药。接触MCP与亚细胞水平上分子生理学的改变有关。本研究调查了N-乙酰半胱氨酸(NAC)对MCP暴露介导的大鼠肝组织线粒体功能障碍的疗效。雄性Wistar大鼠连续28天经胃内给予NAC(200mg/kg体重)、MCP(0.9mg/kg体重)以及NAC与MCP的混合物。使用生化分析评估线粒体复合物活性。使用聚合酶链反应分析线粒体复合物亚基、PGC-1α及其下游调节因子的mRNA表达。MCP(0.9mg/kg体重,经胃内给予,28天)暴露降低了线粒体复合物活性以及复合物亚基的基因表达。PGC-1α、NRF-1、NRF-2和Tfam的表达也显著降低。NAC(200mg/kg体重,经胃内给予,28天)给药显著增加了线粒体复合物活性以及复合物亚基的基因表达。此外,NAC还维持了线粒体功能,并增强了PGC-1α及其下游调节因子的基因表达。本研究结果表明,NAC可预防肝线粒体功能障碍并维持PGC-1α信号传导。总之,可以推测NAC可能是一种用于治疗毒性暴露后线粒体功能障碍的药物。